PT - JOURNAL ARTICLE AU - Lyng, KD AU - Larsen, JB AU - Birnie, K AU - Stinson, J AU - Hoegh, M AU - Olesen, AE AU - Arendt-Nielsen, L AU - Ehlers, L AU - Fonager, K AU - Jensen, MB AU - Würtzen, H AU - Palsson, TS AU - Poulin, P AU - Handberg, G AU - Ziegler, C AU - Møller, LB AU - Olsen, J AU - Heise, L AU - Rathleff, MS TI - Participatory Research: A Priority Setting Partnership for Chronic Musculoskeletal Pain in Denmark AID - 10.1101/2021.12.17.21267948 DP - 2021 Jan 01 TA - medRxiv PG - 2021.12.17.21267948 4099 - http://medrxiv.org/content/early/2021/12/17/2021.12.17.21267948.short 4100 - http://medrxiv.org/content/early/2021/12/17/2021.12.17.21267948.full AB - Background Patient and stakeholder engagements in research have increasingly gained attention in healthcare and healthcare-related research. A common and rigorous approach to establish research priorities based on input from people and stakeholders is the James Lind Alliance Priority Setting Partnership (JLA-PSP). The aim of this study was to establish research priorities for chronic musculoskeletal (MSK) pain by engaging with humans living with chronic MSK pain, relatives to humans living with chronic MSK pain, healthcare professionals (HCP), and researchers working with chronic MSK pain.Methods This JLA-PSP included a nation-wide survey in Denmark, an interim prioritisation, and an online consensus building workshop. The information gained from this was the basis for developing the final list of specific research priorities within chronic MSK pain.Results In the initial survey, 1010 respondents (91% people living with chronic MSK pain/relatives, 9% HCPs/researchers) submitted 3121 potential questions. These were summarised into 19 main themes and 36 sub-themes. In the interim prioritisation exercise, 51% people living with pain/relatives and 49% HCPs/researchers reduced the list to 33 research questions prior to the final priority setting workshop. 23 participants attended the online workshop (12 people/relatives, 10 HCPs, and 1 researcher) who reached consensus for the most important research priorities after two rounds of discussion of each question.Conclusion This study identified several specific research questions generated by people living with chronic MSK pain, relatives, HCPs, and researchers. The stakeholders proposed prioritization of the healthcare system’s ability to support patients, focus on developing coherent pathways between sectors and education for both patients and HCP. These research questions can form the basis for future studies, funders, and be used to align research with end-users’ prioritiesCompeting Interest StatementMH has received support from non-industrial professional, private and scientific bodies (reimbursement of travel costs and speaker fees) for lectures on pain, and he receives book royalties from Gyldendal, Munksgaard Denmark, FADL and Muusmann publications. Otherwise, no authors has any competing interest.Funding StatementThe Association of Danish Physiotherapists Research Foundation is acknowledged for provided funding for the study but was not included in any steps of the design, data acquisition, analysis, or interpretation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was exempt from a full ethical approval by the North Denmark Ethical Committee due to the design of the study.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript.